Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial
2022The LancetJournalOpen access
10.1016/s0140-6736(22)02076-1Full text1,099 citations